Right ventricular function during one-lung ventilation: effects of pressure-controlled and volume-controlled ventilation.
Abdullah M Al Shehri, Mohamed R El-Tahan, Roshdi Al Metwally...
https://pubmed.ncbi.nlm.nih.gov/24447503/Actively Recruiting
Led by Mayo Clinic · Updated on 2026-08-10
75
Participants Needed
1
Research Sites
17 weeks
Total Duration
This research evaluates ventilatory modes for patients admitted to the cardiac intensive care unit CICU who require invasive mechanical ventilation due to cardiac disease complicated by respiratory failure. The study addresses the challenge that positive pressure ventilation and sedation can negatively affect heart function and blood flow in these critically ill patients. Since current evidence on optimal ventilation methods in this setting is limited, this pilot trial aims to assess the feasibility of comparing pressure-controlled and volume-controlled ventilation in this population. Participants will receive one of two ventilatory modes during invasive mechanical ventilation in the CICU pressure-controlled ventilation, which delivers breaths with preset airway pressure above positive end-expiratory pressure, or volume-controlled ventilation, which delivers breaths with preset inspiratory flow and tidal volume. The trial uses a cluster-randomized crossover design to pragmatically compare these two modes over the course of mechanical ventilation expected to last more than 12 hours. During the study, researchers will monitor adherence to the assigned ventilation mode and the timing of its initiation within 48 hours of enrollment. They will also assess clinical outcomes such as in-hospital mortality, ventilator-free days, organ failure-free survival, ICU length of stay, and safety measures including sedation levels and patient-ventilator synchrony up to 28 days. The study aims to gather data on how these ventilation methods affect heart and lung function in critically ill cardiac patients.
CONDITIONS
COMPARE-VENT Feasibility Pilot Study
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mayo Clinic
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Pressure-Controlled Ventilation | Volume-Controlled Ventilation |
|---|---|---|
| What it is | Pressure-controlled ventilation delivers mandatory breaths with a preset inspiratory pressure above positive end-expiratory pressure to manage gas exchange in patients with respiratory failure. | Volume-controlled ventilation provides mandatory breaths with a preset tidal volume and inspiratory flow to achieve target minute ventilation for patients needing mechanical support. |
| Primary use | Used to manage respiratory failure in critically ill adults, allowing clinicians to control airway pressure and optimize oxygenation, particularly for patients with compromised cardiac status. | Applied to support ventilation in critically ill adults, providing control over delivered tidal volume and ensuring stable ventilation parameters for cardiac ICU patients. |
| Administration | Mechanical ventilators are set to deliver breaths at a constant pressure above baseline, adjusting inspiratory time and pressure based on patient needs. | Mechanical ventilators are set to deliver a fixed tidal volume and preset inspiratory flow, allowing adjustment to optimize patient ventilation and reduce risk of overinflation. |
| Evidence status | Pressure-controlled ventilation is supported by clinical trials and meta-analyses as an established ventilation mode, but evidence for superiority in critically ill cardiac patients remains mixed. | Volume-controlled ventilation is widely used, with randomized trials showing no clear advantage over pressure-controlled ventilation in duration of ventilation or survival in broad ICU adult populations. |
| Important limitations | Pressure-controlled ventilation can result in unpredictable tidal volumes if lung compliance changes and may require careful monitoring in patients with cardiac dysfunction. | Volume-controlled ventilation may lead to excessive airway pressures if lung compliance decreases, potentially increasing risk of barotrauma especially in patients with stiff lungs or cardiac conditions. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Expected duration of mechanical ventilation over 12 hours
Participants receive either pressure-controlled or volume-controlled ventilation during invasive mechanical ventilation in the cardiac ICU as part of the study.
Monitoring during ventilation up to 48 hours and clinical outcomes assessed up to 28 days
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Abdullah M Al Shehri, Mohamed R El-Tahan, Roshdi Al Metwally...
https://pubmed.ncbi.nlm.nih.gov/24447503/Kevin P Seitz, Bradley D Lloyd, Li Wang...
https://pubmed.ncbi.nlm.nih.gov/39417127/Yongfang Zhou, Steven R Holets, Man Li...
https://pubmed.ncbi.nlm.nih.gov/34117278/Carlos L Alviar, P Elliott Miller, Dorothea McAreavey...
https://pubmed.ncbi.nlm.nih.gov/30236315/Kyu Nam Kim, Dong Won Kim, Mi Ae Jeong...
https://pubmed.ncbi.nlm.nih.gov/27581657/Nuttapol Rittayamai, Christina M Katsios, François Beloncle...
https://pubmed.ncbi.nlm.nih.gov/25927671/Xue-Fei Li, Wen-Jie Mao, Rong-Juan Jiang...
https://pubmed.ncbi.nlm.nih.gov/38105126/Mayo Clinic
Lead Sponsor